Gliclazide 40mg/5ml oral suspension
BNF presentation 0601021M0AAAUAU within chapter Endocrine System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0601021M0AAAUAU
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
171
NHS spend (£)
£4,344.10
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 30 |
| December 2024 | 7 |
| November 2024 | 27 |
| October 2024 | 27 |
| July 2024 | 38 |
| May 2024 | 1 |
| July 2021 | 6 |
| June 2021 | 6 |
| December 2020 | 13 |
| November 2020 | 16 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 16 | No data available |
| Unknown pharmacy | 6 | No data available |
|
Longshore Surgeries
ODS D83010
|
6 | 26A - NORFOLK AND WAVENEY ICB |
|
Sampford Peverell Surgery
ODS L83616
|
5 | 15N - DEVON ICB |
| Unknown pharmacy | 5 | No data available |
| Unknown pharmacy | 5 | No data available |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 4 | No data available |